<p>Forbes India's Manu Balachandran talks about Vasant 'Vas' Narasimhan, CEO, Novartis, the youngest amongst his pharma peers at 47, a trained doctor who has come up the ranks from R&D. Balachandran delves into our latest cover story which dissects Novartis' play in India</p>

Forbes India's Manu Balachandran talks about Vasant 'Vas' Narasimhan, CEO, Novartis, the youngest amongst his pharma peers at 47, a trained doctor who has come up the ranks from R&D. Balachandran delves into our latest cover story which dissects Novartis' play in India

<p>Forbes India's Manu Balachandran talks about Vasant 'Vas' Narasimhan, CEO, Novartis, the youngest amongst his pharma peers at 47, a trained doctor who has come up the ranks from R&amp;D. Balachandran delves into our latest cover story which dissects Novartis' play in India</p>

Inside Novartis' outsized play in India

Forbes India in association with TheIndicast.com bring you conversations with the people behind the Forbes India Magazine. Listen to what went in developing the cover story and special reports in the latest issue of the Forbes India Magazine along with expert insights on the top news from one of the most vibrant world economies

Share Inside Novartis' outsized play in India

Sign up to save your podcasts

Inside Novartis' outsized play in India

Inside Novartis' outsized play in India

More shows like Inside Forbes India

TED Talks Daily

World Business Report

The McKinsey Podcast

TED Tech

Cyrus Says

Moneycontrol Podcast

3 Things

FT News Briefing

ThePrint

In Focus by The Hindu

Finshots Daily

Top of the Morning

The Morning Brief

Daybreak

The Daily Brief